SHAREHOLDER ALERT: Ongoing Securities Fraud Litigation Against Orthofix Medical (OFIX)

Philadelphia, Pennsylvania–(Newsfile Corp. – August 23, 2024) – Berger Montague PC informs investors that a securities fraud class action lawsuit has been filed against Orthofix Medical, Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) on behalf of purchasers of Orthofix securities between October 11, 2022 and September 12, 2023, inclusive (the “Class Period”).

Investor Deadline: Investors who purchased or acquired Orthofix securities during the Class Period may request to be appointed as a lead plaintiff representative of the class no later than October 21, 2024. For additional information or to learn how to participate in this litigation, contact Berger Montague: Andrew Abramowitz at [email protected] or (215) 875-3015, or Peter Hamner at [email protected]
or (215) 875-3048, or CLICK HERE.